tm logo
SUZEMO
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 04 Sep 2023

Last Applicant/ Owned by

Route 206 & Province Line Road

Princeton

NJ

08543

Serial Number

90605994 filed on 26th Mar 2021

Registration Number

N/A

Correspondent Address

Marilyn F. Kelly

BRISTOL-MYERS SQUIBB COMPANY

P.O. BOX 4000

TRADEMARK DEPT., MAILSTOP D.4243

PRINCETON,NJ 08648-4000

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

SUZEMO

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloprolRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies

Mark Details


Serial Number

No 90605994

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 00159597-US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
05th Sep 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
04th Sep 2023ABANDONMENT - NO USE STATEMENT FILED
02th Aug 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
02th Aug 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02th Aug 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
31st Jan 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06th Dec 2022PUBLISHED FOR OPPOSITION
06th Dec 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16th Nov 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31st Oct 2022EXAMINERS AMENDMENT -WRITTEN